Review
Clopidogrel and thrombotic thrombocytopenic purpura: No clear case for causality
Navneet S. Majhail, MBBS, MD and Alan E. Lichtin, MD
Cleveland Clinic Journal of Medicine May 2003, 70 (5) 466-470;
Navneet S. Majhail
Department of Internal Medicine, The Cleveland Clinic
Alan E. Lichtin
Department of Hematology and Medical Oncology, The Cleveland Clinic

Article Information
vol. 70 no. 5 466-470
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online May 1, 2003.
Copyright & Usage
Copyright © 2003 The Cleveland Clinic Foundation. All Rights Reserved.
In this issue
Cleveland Clinic Journal of Medicine
Vol. 70, Issue 5
1 May 2003
Clopidogrel and thrombotic thrombocytopenic purpura: No clear case for causality
Navneet S. Majhail, Alan E. Lichtin
Cleveland Clinic Journal of Medicine May 2003, 70 (5) 466-470;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Two Mechanistic Pathways for Thienopyridine-Associated Thrombotic Thrombocytopenic Purpura: A Report From the SERF-TTP Research Group and the RADAR Project
- Long-Term Therapy to Prevent Stroke
- Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome associated with clopidogrel: report of two new cases
- Clopidogrel-Associated TTP: An Update of Pharmacovigilance Efforts Conducted by Independent Researchers, Pharmaceutical Suppliers, and the Food and Drug Administration





